JP Morgan Chase
MBX

JP Morgan Chase’s MBX Biosciences MBX Stock Holding History

JP Morgan Chase’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.96M Buy
147,057
+132,412
+904% +$4.5M ﹤0.01% 3541
2025
Q4 		$462K Buy
14,645
+8,470
+137% +$206K ﹤0.01% 5098
2025
Q3 		$108K Sell
6,175
-2,009
-25% -$26.9K ﹤0.01% 5861
2025
Q2 		$93.4K Sell
8,184
-193,051
-96% -$1.97M ﹤0.01% 5637
2025
Q1 		$1.49M Buy
201,235
+192,129
+2,110% +$2.03M ﹤0.01% 4076
2024
Q4 		$168K Buy
+9,106
New +$194K ﹤0.01% 5554

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

JP Morgan Chase's MBX Position: Q1 2026 in Review

JP Morgan Chase increased its MBX Biosciences (MBX) stake by 904% in Q1 2026, buying an estimated $4.5M and bringing the position to 147,057 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

JP Morgan Chase first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • JP Morgan Chase held 147,057 shares of MBX Biosciences worth $3.96M as of Q1 2026.
  • JP Morgan Chase bought 132,412 MBX Biosciences shares in Q1 2026, an estimated $4.5M.
  • MBX Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3541 holding.
  • JP Morgan Chase first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.